Donald School Journal of Ultrasound in Obstetrics and Gynecology

Register      Login

VOLUME 15 , ISSUE 1 ( January-March, 2021 ) > List of Articles


Obesity in Pregnancy: A New Chapter in Obstetrics

Citation Information : Obesity in Pregnancy: A New Chapter in Obstetrics. Donald School J Ultrasound Obstet Gynecol 2021; 15 (1):43-48.

DOI: 10.5005/jp-journals-10009-1679

License: CC BY-NC 4.0

Published Online: 01-03-2021

Copyright Statement:  Copyright © 2021; The Author(s).


Obesity is a worldwide health problem affecting more than 35% of the adult population in the USA. Obesity is the greatest epidemic ever experienced by humans and resulting from increasing population increasing lifespan, urbanization, plentiful food and physical inactivity. The rate of obesity has doubled over the past decade. Percentage of women who are overweight or obese has increased by 60% over the past 30 years. The mean BMI has increased over the past 20 years leading to adverse metabolic effects on blood pressure, cholesterol and triglyceride concentration and insulin resistance, thereby increasing the risk: (1) for coronary disease and ischemic stroke, (2) for type 2 diabetes, and (3) for polycystic ovary syndrome (PCOS). Maternal obesity in pregnancy (MOP) has been associated with fertility implications both genders pregnancy complication, such as preterm delivery, shoulder dystocia, and adverse outcome including hypertensive disorders, gestational diabetes and need for operative delivery (cesarean section and instrumental vaginal delivery). Maternal obesity also has a significant impact on fetal development on neonatal period and overall on childhood development. Modification to routine prenatal care has been suggested for this population such as screening for diabetes in early pregnancy, limiting gestational weight gain, routine ultrasound for gestational age, fetal anatomic survey and antenatal surveillance with NST and BPP scoring and fetal echocardiography, screening for fetal aneuploidy. Obesity can affect screening test performance. Cell-free fetal DNA screening is more likely to result in test failure, low-dose aspirin to reduce the risk of preeclampsia and evaluation by anesthesiologist. Delivery timing and indications for labor induction should not be altered based on maternal obesity. For women undergoing cesarean delivery, prophylactic antibiotics should be administered based on maternal weight.

  1. Gallagher D, Visser M, Sepulveda D, et al. How useful is body mass index for comparison of body fatness across age, sex, and ethnic groups? Am J Epidemiol 1996;143(3):228. DOI: 10.1093/oxfordjournals.aje.a008733.
  2. Mei Z, Grummer-Strawn LM, Pietrobelli A, et al. Validity of body mass index compared with other body-composition screening indexes for the assessment of body fatness in children and adolescents. Am J Clin Nutr 2002;75(6):978–985. DOI: 10.1093/ajcn/75.6.978.
  3. Prospective Studies Collaboration, Lewington S, Sherliker P, et al. Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Lancet 2009;373(9669):1083–1096. DOI: 10.1016/S0140-6736(09)60318-4.
  4. Ramsay JE, Ferrell WR, Crawford L, et al. Maternal obesity is associated with dysregulation of metabolic, vascular, and inflammatory pathways. J Clin Endocrinol Metab 2002;87(9):4231–4237. DOI: 10.1210/jc.2002-020311.
  5. Catalano PM, Shankar K. Obesity and pregnancy: mechanisms of short term and long term adverse consequences for mother and child. BMJ 2017;356:j1. DOI: 10.1136/bmj.j1.
  6. Tyrrell J, Richmond RC, Palmer TM, et al. Genetic evidence for causal relationships between maternal obesity-related traits and birth weight. JAMA 2016;315(11):1129–1140. DOI: 10.1001/jama.2016.1975.
  7. Institute of medicine (US) and national research council (US) committee to reexamine IOM pregnancy weight guidelines. In: Rasmussen KM, Yaktine AL, ed. Weight Gain During Pregnancy: Reexamining the Guidelines. Washington, DC: National Academies Press (US); 2009.
  8. Cedergren MI. Maternal morbid obesity and the risk of adverse pregnancy outcome. Obstet Gynecol 2004;103(2):219–224. DOI: 10.1097/01.AOG.0000107291.46159.00.
  9. American College of Obstetricians and Gynecologists. ACOG committee opinion no. 549: obesity in pregnancy. Obstet Gynecol 2013;121(1):213–217. DOI: 10.1097/01.AOG.0000425667.10377.60.
  10. Barker DJP, Osmond C, Winter PD, et al. Weight in infancy and death from ischaemic heart disease. Lancet 1989;2(8663):577–580. DOI: 10.1016/S0140-6736(89)90710-1.
  11. Paneth N, Susser M. Early origin of coronary heart disease (the “Barker hypothesis”). BMJ 1995;310(6977):411–412. DOI: 10.1136/bmj.310.6977.411.
  12. Heslehurst N, Simpson H, Ells LJ, et al. The impact of maternal BMI status on pregnancy outcomes with immediate short-term obstetric resource implications: a meta-analysis. Obes Rev 2008;9(6):635–683. DOI: 10.1111/j.1467-789X.2008.00511.x.
  13. Birdsall KM, Vyas S, Khazaezadeh N, et al. Maternal obesity: a review of interventions. Int J Clin Pract 2009;63(3):494–507. DOI: 10.1111/j.1742-1241.2008.01910.x.
  14. Lu GC, Rouse DJ, DuBard M, et al. The effect of the increasing prevalence of maternal obesity on perinatal morbidity. Am J Obstet Gynecol 2001;185(4):845–849. DOI: 10.1067/mob.2001.117351.
  15. Stothard KJ, Tennant PWG, Bell R, et al. Maternal overweight and obesity and the risk of congenital anomalies: a systematic review and meta-analysis. JAMA 2009;301(6):636–650. DOI: 10.1001/jama.2009.113.
  16. Bellver J, Melo MAB, Bosch E, et al. Obesity and poor reproductive outcome: the potential role of the endometrium. Fertil Steril 2007;88(2):446–451. DOI: 10.1016/j.fertnstert.2006.11.162.
  17. Esakoff TF, Sparks TN, Kaimal AJ, et al. Diagnosis and morbidity of placenta accrete. Ultrasound Obstet Gynecol 2011;37(3):324–327. DOI: 10.1002/uog.8827.
  18. Khong TY. The pathology of placenta accreta, a worldwide epidemic. J Clin Pathol 2008;61(12):1243–1246. DOI: 10.1136/jcp.2008.055202.
  19. Catalano PM, Kirwan JP, Haugel-de Mouzon S, et al. Gestational diabetes and insulin resistance: role in short- and long-term implications for mother and fetus. J Nutr 2003;133(5):1674S–1683SS. DOI: 10.1093/jn/133.5.1674S.
  20. Gaillard R, Steegers EA, Hofman A, et al. Associations of maternal obesity with blood pressure and the risks of gestational hypertensive disorders. The generation R study. J Hypertens 2011;29(5):937–944. DOI: 10.1097/HJH.0b013e328345500c.
  21. Silver RM, Landon MB, Rouse DJ, et al. Maternal morbidity associated with multiple repeat cesarean deliveries. Obstet Gynecol 2006;107(6):1226–1232. DOI: 10.1097/01.AOG.0000219750.79480.84.
  22. Sibai BM, Ewell M, Levine RJ, et al. Risk factors associated with preeclampsia in healthy nulliparous women. The calcium for preeclampsia prevention (CPEP) study group. Am J Obstet Gynecol 1997;177(5):1003–1010. DOI: 10.1016/S0002-9378(97)70004-8.
  23. Gross T, Sokol RJ, King KC. Obesity in pregnancy: risks and outcome. Obstet Gynecol 1980;56:446–450.
  24. Torloni MR, Betrán AP, Horta BL, et al. Prepregnancy BMI and the risk of gestational diabetes: a systematic review of the literature with meta-analysis. Obes Rev 2009;10(2):194–203. DOI: 10.1111/j.1467-789X.2008.00541.x.
  25. Chu SY, Callaghan WM, Kim SY, et al. Maternal obesity and risk of gestational diabetes mellitus. Diabetes Care 2007;30(8):2070–2076. DOI: 10.2337/dc06-2559a.
  26. Lockwood CJ, Huang SJ, Chen CP, et al. Decidual cell regulation of natural killer cell-recruiting chemokines: implications for the pathogenesis and prediction of preeclampsia. Am J Pathol 2013;183(3):841–856. DOI: 10.1016/j.ajpath.2013.05.029.
  27. McDonald SD, Han Z, Mulla S, et al. Overweight and obesity in mothers and risk of preterm birth and low birth weight infants: systematic review and meta-analyses. BMJ 2010;341(jul20 1):c3428. DOI: 10.1136/bmj.c3428.
  28. Palomba S, Falbo A, Chiossi G, et al. Low-grade chronic inflammation in pregnant women with polycystic ovary syndrome: a prospective controlled clinical study. J Clin Endocrinol Metab 2014;99(8):2942–2951. DOI: 10.1210/jc.2014-1214.
  29. Denison F, Price J, Graham C, et al. Maternal obesity, length of gestation, risk of postdates pregnancy and spontaneous onset of labour at term. BJOG 2008;115(6):720–725. DOI: 10.1111/j.1471-0528.2008.01694.x.
  30. Simic M, Wåhlin IA, Marsál K, et al. Maternal obesity is a potential source of error in mid-trimester ultrasound estimation of gestational age. Ultrasound Obstet Gynecol 2010;35(1):48–53. DOI: 10.1002/uog.7502.
  31. Naeye RL. Maternal body weight and pregnancy outcome. Am J Clin Nutr 1990;52(2):273–279. DOI: 10.1093/ajcn/52.2.273.
  32. Nylander PP. The factors that influence twinning rates. Acta Genet Med Gemellol (Roma) 1981;30(3):189–202. DOI: 10.1017/S0001566000007650.
  33. O’Reilly JR, Reynolds RM. The risk of maternal obesity to the long-term health of the offspring. Clin Endocrinol (Oxf) 2013;78(1):9–16. DOI: 10.1111/cen.12055.
  34. Brost BC, Goldenberg RL, Mercer BM, et al. The preterm prediction study: association of cesarean delivery with increases in maternal weight and body mass index. Am J Obstet Gynecol 1997;177(2):333–337. DOI: 10.1016/S0002-9378(97)70195-9.
  35. Lo TK, Yung WK, Lau WL, et al. Planned conservative management of placenta accreta—experience of a regional general hospital. J Matern Fetal Neonatal Med 2014;27(3):291–296. DOI: 10.3109/14767058.2013.818118.
  36. Cohen WR, Hayes-Gill B. Influence of maternal body mass index on accuracy and reliability of external fetal monitoring techniques. Acta Obstet Gynecol Scand 2014;93(6):590–595. DOI: 10.1111/aogs.12387.
  37. Schuster M, Madueke-Laveaux OS, Mackeen AD, et al. The effect of the MFM obesity protocol on cesarean delivery rates. Am J Obstet Gynecol 2016;215(4):492.e1-6. DOI: 10.1016/j.ajog.2016.05.005.
  38. Yao R, Ananth CV, Park BY, et al. Obesity and the risk of stillbirth: a population-based cohort study. Am J Obstet Gynecol 2014;210(5):457.e1-9. DOI: 10.1016/j.ajog.2014.01.044.
  39. Frentzen BH, Dimperio DL, Cruz AC. Maternal weight gain: effect on infant birth weight among overweight and average-weight low-income women. Am J Obstet Gynecol 1988;159(5):1114–1117. DOI: 10.1016/0002-9378(88)90424-3.
  40. Calandra C, Abell DA, Beischer NA. Maternal obesity in pregnancy. Obstet Gynecol 1981;57:8–12.
  41. Jauniaux E, Jurkovic D. Placenta accreta: pathogenesis of a 20th century iatrogenic uterine disease. Placenta 2012;33(4):244–251. DOI: 10.1016/j.placenta.2011.11.010.
  42. Kevane B, Donnelly J, D’Alton M, et al. Risk factors for pregnancy-associated venous thromboembolism: a review. J Perinat Med 2014;42(4):417–425. DOI: 10.1515/jpm-2013-0207.
  43. Molyneaux E, Poston L, Ashurst-Williams S, et al. Obesity and mental disorders during pregnancy and postpartum: a systematic review and meta-analysis. Obstet Gynecol 2014;123(4):857–867. DOI: 10.1097/AOG.0000000000000170.
  44. Rasmussen SA, Chu SY, Kim SY, et al. Maternal obesity and risk of neural tube defects: a meta-analysis. Am J Obstet Gynecol 2008;198(6):611–619. DOI: 10.1016/j.ajog.2008.04.021.
  45. Cai G, Sun X, Zhang L, et al. Association between maternal body mass index and congenital heart defects in offspring: a systematic review. Am J Obstet Gynecol 2014;211(2):91–117. DOI: 10.1016/j.ajog.2014.03.028.
  46. Wolfe BM, Kvach E, Eckel RH. Treatment of obesity: weight loss and bariatric surgery. Circ Res 2016;118(11):1844–1855. DOI: 10.1161/CIRCRESAHA.116.307591.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.